NDC 81802-001

CUVRIOR

Trientine Tetrahydrochloride

CUVRIOR is a Oral Tablet, Film Coated in the Human Prescription Drug category. It is labeled and distributed by Orphalan Sa. The primary component is Trientine Tetrahydrochloride.

• Product ID: 81802-001_59a6b94d-79f1-4ed9-9c61-e44f907b1e2b
• NDC: 81802-001
• Product Type: Human Prescription Drug
• Proprietary Name: CUVRIOR
• Generic Name: Trientine Tetrahydrochloride
• Dosage Form: Tablet, Film Coated
• Route of Administration: ORAL
• Marketing Start Date: 2022-09-14
• Marketing Category: NDA /
• Application Number: NDA215760
• Labeler Name: Orphalan SA
• Substance Name: TRIENTINE TETRAHYDROCHLORIDE
• Active Ingredient Strength: 300 mg/1
• Pharm Classes: Metal Chelating Activity [MoA], Metal Chelator [EPC]
• NDC Exclude Flag: N
• Listing Certified Through: 2023-12-31

Packaging

NDC 81802-001-72

9 CARTON in 1 CARTON (81802-001-72) > 1 BLISTER PACK in 1 CARTON (81802-001-08) > 8 TABLET, FILM COATED in 1 BLISTER PACK

• Marketing Start Date: 2022-09-14
• NDC Exclude Flag: N
• Sample Package?: N

Drug Details